Johnson & Johnson (NYSE: JNJ) has experienced its fair share of product quality issues in the past. Now, the healthcare giant has another one on its hands with a voluntary recall of some of its spray sunscreen products. In this Motley Fool Live video recorded on July 19, healthcare and cannabis bureau chief Corinne Cardina and Motley Fool contributor Keith Speights discuss how this latest recall might impact J&J.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting